In the fiscal year 2022, the Japanese company Chugai Pharmaceutical Co., Ltd. spent approximately 143.7 billion Japanese yen on research and development, the highest expenses of the past decade.
One of the main products developed by the company is "Actemra". As of this report, Actemra is the only biological product developed in Japan and was approved for sales in both the United States and Europe. Biological products are products made from various natural resources, such as sugars, proteins, or nucleic acids.
Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022
(billion Japanese yen)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Chugai Pharmaceutical. (May 31, 2023). Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (billion Japanese yen) [Graph]. In Statista. Retrieved December 27, 2024, from https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/
Chugai Pharmaceutical. "Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (billion Japanese yen)." Chart. May 31, 2023. Statista. Accessed December 27, 2024. https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/
Chugai Pharmaceutical. (2023). Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (billion Japanese yen). Statista. Statista Inc.. Accessed: December 27, 2024. https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/
Chugai Pharmaceutical. "Total Research and Development (R&d) Expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (Billion Japanese Yen)." Statista, Statista Inc., 31 May 2023, https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/
Chugai Pharmaceutical, Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (billion Japanese yen) Statista, https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/ (last visited December 27, 2024)
Total research and development (R&D) expenses of Chugai Pharmaceutical Co., Ltd. in Japan from 2013 to 2022 (billion Japanese yen) [Graph], Chugai Pharmaceutical, May 31, 2023. [Online]. Available: https://www.statista.com/statistics/1044336/chugai-pharmaceutical-research-and-development-expenditure/
